Analysis of Prenatal Diagnosis and Pregnancy Decisions of 767 Singleton Pregnancies With Positive Prenatal Cell-Free DNA Screening Results in Southwest China

This study explored the associations between positive cell‐free DNA (cfDNA) screening results and the decisions made by pregnant women regarding invasive diagnosis and continuation of pregnancy.

• Publication year

  2025

• Venue

  Journal of Pregnancy

• Publication date

  2025-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/jp/8877014PMID 41267889PMCID 12629691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determining the origin of genome aberrations improves the positive predictive value of NIPT for 22q11.2 deletion syndrome

  2025influential reference
• Prenatal cfDNA sequencing and incidental detection of maternal cancer

  2024cited by this paper
• The role of a multidisciplinary team in managing variants of uncertain clinical significance in prenatal genetic diagnosis.

  2023cited by this paper
• Position statement from the International Society for Prenatal Diagnosis on the use of non‐invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies

  2023cited by this paper
• Receiving uncertain results from prenatal chromosomal microarray analysis: Women's decisions on continuation or termination of pregnancy

  2023cited by this paper
• Clinical utility of expanded non‐invasive prenatal screening compared with chromosomal microarray analysis in over 8000 pregnancies without major structural anomaly

  2023influential reference
• Non-invasive prenatal test findings in 41,819 pregnant women: results from a clinical laboratory in southern China

  2023cited by this paper
• Placental, maternal, fetal and technical origins of false-positive cell-free DNA screening results.

  2023cited by this paper
• Efficiency of expanded noninvasive prenatal testing in the detection of fetal subchromosomal microdeletion and microduplication in a cohort of 31,256 single pregnancies

  2022influential reference
• Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).

  2022cited by this paper
• Investigation on combined copy number variation sequencing and cytogenetic karyotyping for prenatal diagnosis

  2021cited by this paper
• The application of expanded noninvasive prenatal screening for genome-wide chromosomal abnormalities and genetic counseling

  2021influential reference
• To offer or request? Disclosing variants of uncertain significance in prenatal testing

  2021cited by this paper
• DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects

  2021cited by this paper
• Fetal Aneuploidy: Screening and Diagnostic Testing.

  2020cited by this paper
• Screening for Fetal Chromosomal Abnormalities.

  2020cited by this paper
• FF‐QuantSC: accurate quantification of fetal fraction by a neural network model

  2020cited by this paper
• Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226.

  2020cited by this paper
• An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study

  2019influential reference
• TRIDENT-2: National Implementation of Genome-Wide Non-Invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.

  2019cited by this paper
• Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features

  2019cited by this paper
• Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes

  2019influential reference
• Current controversies in prenatal diagnosis 2: Cell‐free DNA prenatal screening should be used to identify all chromosome abnormalities

  2018cited by this paper
• Identification of copy number variations among fetuses with ultrasound soft markers using next-generation sequencing

  2018cited by this paper
• ACMG 2016 Update on Noninvasive Prenatal Testing for Fetal Aneuploidy: Implications for India

  2017cited by this paper
• ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis

  2016influential reference
• Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics

  2016cited by this paper
• Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology

  2016cited by this paper
• Committee Opinion No. 640: Cell-Free Dna Screening For Fetal Aneuploidy

  2015cited by this paper
• Counseling Challenges with Variants of Uncertain Significance and Incidental Findings in Prenatal Genetic Screening and Diagnosis

  2014cited by this paper
• De novo mutations in human genetic disease

  2012cited by this paper
• Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies

  2012cited by this paper
• Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth.

  2012cited by this paper

• No citing papers are available for this paper.